GBA1 and Parkinson disease: Here, we assessed whether a brain penetrant SCD inhibitor, 5b, can prevent the PD-like neuropathology in GBA1 mutant neuronal culture and in 2 Gba1 mutant mouse lines, expressing either the more common and severe L444P mutation or the E326K mutation—both risk factors for the development of PD (74, 75).